Tyler Lindgren is an Associate Scientist II at BridgeBio, where responsibilities include the execution and review of release assays and the development of methods for characterizing rAAV products and impurities. Previously, as an Associate Scientist in Bioassay-Analytical Development at BridgeBio, Tyler conducted routine experiments to support rAAV processes and ensured timely data analysis. Prior experience includes an internship at Novartis Gene Therapies, focusing on AAV analytical assay development and automated DNA extraction, as well as serving as a Teaching Assistant at Penn State University. Tyler holds a Bachelor of Science in Biotechnology from Penn State University and a Master of Science in Applied Biotechnology from the University of Wisconsin-Madison.